MitoLab

About:

MitoLab is a biotechnology company building a scalable platform for mitochondrial genome engineering.

Top Investors: The E14 Fund

Description:

MitoLab is a biotechnology company building a scalable platform for mitochondrial genome engineering. It creates and sells products for use in non-clinical scientific research scenarios. The company’s products are designed to be used in non-clinical research projects assessing the utility of chemical compounds for mitochondrial medicine. Their customers range from multinational companies to individuals specializing in mitochondrial, metabolic, and anti-aging research. Founded by Fahim Farzadfard and Louis J. Kang in 2020 and is headquartered in Allston, Massachusetts, USA.

Total Funding Amount:

$2.72M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Allston, Massachusetts, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)mitolab.com

Founders:

Fahim Farzadfard, Louis J. Kang

Number of Employees:

1-10

Last Funding Date:

2020-04-01

IPO Status:

Private

Industries: